Education Zone
touchIME is the education division of touchONCOLOGY, we pride ourselves on providing innovative independent learning activities for busy healthcare professionals.
Get up to date on the data for emerging treatment options for patients with HER2-positive breast cancer and brain metastases and how they may influence clinical practice by watching these short interviews with breast cancer experts.
Watch a panel of eminent cancer nursing experts discuss the impact of the COVID-19 pandemic on cancer care delivery in Europe, including how patients and their families are themselves affected, and may be best supported during this time.
Watch Dr Robert Doebele, an internationally renowned expert in lung cancer, discuss the latest scientific understanding of the mechanisms of resistance to anaplastic lymphoma kinase (ALK) inhibitors and their clinical impact, and share best practice for ALK profiling in patients with non-small cell lung cancer (NSCLC).
Get an update on CAR-T therapy in clinical practice with this expert discussion on real-world data, patient referral and the important collaboration between referral and treatment centres.
Watch leading international experts in breast cancer translate outcomes from key clinical trials investigating CDK4/6 inhibitors in HR+/HER2- advanced breast cancer into daily practice.
Watch Dr King, an internationally renowned oncology expert, discuss the latest data on human epidermal growth factor receptor-targeted antibody-drug conjugates for the treatment of breast cancer.
Watch a panel of internationally renowned multiple myeloma experts discuss the management of relapsed/refractory disease and the future for B-cell maturation antigen (BCMA)-targeted agents.
Watch world-leading expert Professor Régis Peffault de Latour explore the current treatment landscape in paroxysmal nocturnal hemoglobinuria, with a focus on translating this latest scientific evidence into clinical practice.
Watch a panel of internationally renowned Waldenström’s macroglobulinemia experts discuss the clinical utility of second-generation Bruton’s tyrosine kinase (BTK) inhibitors, and their potential impact on the current treatment paradigm.
Watch leading experts involved in the care of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) discuss how recent advances have driven the personalization of treatment options.
Stay abreast of the latest data for PARP inhibitors in the first-line maintenance treatment of advanced ovarian cancer by watching a webinar and interviews with international experts on data from the virtual SGO and ASCO annual meetings 2020.
Find out about the latest data on the use of B-cell maturation antigen (BCMA)-targeted therapies in the management of relapsed/refractory multiple myeloma through our touchCONGRESS Webinar and Expert Interviews with European experts discussing data from ASCO20 Virtual.
Watch a webinar and interviews from global experts on the latest data for EGFR-mutant non-small-cell lung cancer (NSCLC) from the American Society of Clinical Oncology Virtual 2020 Conference (ASCO20 Virtual) and their potential implications for optimizing treatment decisions in clinical practice.
Watch leading expert Prof. Graham Jackson discuss the importance of identifying high-risk patients with relapsed/refractory multiple myeloma and the role of biomarkers and novel therapies in optimizing individual patient care.
Watch ovarian cancer experts discuss the role of PARP inhibitors in first-line maintenance treatment based on the latest data, as well as which factors influence the choice of PARP inhibitor and the management of possible adverse events.
Watch interviews, a webinar and a panel discussion covering the latest developments in EGFR TKIs for patients with NSCLC, from global experts from Europe, the USA and Asia. The experts review the key data from the ESMO Congress 2019 (Barcelona, Spain, 27 September–1 October 2019) and the ESMO Asia Congress 2019 (Singapore, 22–24 November, 2019), as well as provide practical guidance for daily clinical practice.
Watch webinars and interviews that cover the latest developments in CDK4/6 inhibitors for patients with HR+/HER2- advanced breast cancer, from global experts at SABCS, ASCO, ESMO and ESMO Breast Cancer Congress 2019.
Watch the footage from our Satellite Symposium at the International Consensus Conference for Advanced Breast Cancer 2019 (ABC5), with internationally renowned expert faculty discussing the optimization of CDK4/6 inhibitor treatment in patients with advanced breast cancer.
Stay up to date with the latest developments in NSCLC with MET exon 14 skipping alterations with our touchCONGRESS Panel Discussion and Expert Interviews from the European Society for Medical Oncology (ESMO) Annual Meeting in Barcelona 27 September–1 October 2019.
Watch leading clinicians with a broad range of oncology expertise discuss the current challenges in treating solid tumours, what they expect from the 2019 European Society of Medical Oncology (ESMO) Congress, 27 September–1 October 2019, and what the latest data could mean for global and regional clinical practice.
Watch the footage from our Satellite Symposium at the 2019 ESMO Breast Cancer Annual Congress, with an internationally renowned expert faculty discussing the optimization of treatment with CDK4/6 inhibitors in HR+/HER2- breast cancer.
Watch internationally renowned experts discuss the selection of first-line treatments for patients with EGFR+ NSCLC and treatment sequencing, as well as the importance of biomarker testing and the emergence of treatment resistance.
Watch the footage from our Satellite Symposium at the 2019 St. Gallen International Breast Cancer Conference, with an internationally renowned expert faculty discussing the changing landscape for adjuvant treatment of patients with high-risk breast cancer.
Watch internationally renowned experts discuss the diagnosis and management of patients with ALK+ NSCLC, review the changing treatment landscape and consider how to optimize outcomes.
Watch a panel of internationally renowned experts discuss the factors influencing the choice of first-line treatment for patients with advanced soft tissue sarcoma and the interpretation of data from clinical trials in this patient population.
Watch internationally renowned expert, Professor Stephen Johnston, discuss key data in advanced breast cancer presented at the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3–8 December 2018.
Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3-8 December 2018, and what they may mean for global and regional clinical practice.
Watch internationally renowned expert, Dr Javier Cortés, discuss key data in advanced breast cancer presented at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany.
Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, and what they may mean for global and regional clinical practice.
Watch a group of leading breast cancer specialists debate and discuss how to optimize clinical outcomes for patients with advanced HR+/HER2- disease in the era of CDK4/6 inhibition.
Watch internationally renowned breast cancer expert, Professor Nadia Harbeck, discuss key data in advanced breast cancer presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA.
Watch internationally renowned breast cancer clinicians discussing the latest data from the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5, and what they may mean for clinical practice.
Watch internationally renowned breast cancer clinicians discussing the latest data from the American Association for Cancer Research (AACR) Annual Meeting 2018, Chicago, IL, US, April 14–18, and what they may mean for clinical practice.
Watch internationally renowned clinical expert, Professor Angelo Di Leo, discuss key data in advanced breast cancer presented at the 2018 American Association for Cancer Research (AACR) Annual Meeting, Chicago, USA.
